Advertisement

Topics

Genexine, Inc. Company Profile

02:58 EST 18th February 2019 | BioPortfolio

Genexine, Inc., listed on KOSDAQ (095700) since 2009, is a leading biotherapeutics company focused on immuno-oncology and orphan disease. Genexine has robust pipelines in clinical and pre-clinical stages based on long-acting Fc fusion technology and therapeutic DNA technology. In the clinical stage, Genexine has GX-H9 (long-acting human growth hormone, hGH-hyFc) for both adult and pediatric growth hormone deficiencies, currently in multinational phase II trials. GX-188E, therapeutic DNA vaccine for HPV-associated diseases, is in Phase II in Europe and Korea for Cervical Intraepithelial Neoplasia II/III and plans to enter into a Phase 1b/2 trial in cervical cancer in combination with KEYTRUDA, an anti-PD-1 therapy marketed by Merck & Co., Inc., Kenilworth, NJ, USA. Founded in 1999, Genexine has over 150 employees, and half of them are scientists with MSc, or Ph.D. Genexine is located in Pangyo Techno Valley near Seoul, Korea with a branch office in New York.


News Articles [9 Associated News Articles listed on BioPortfolio]

I-Mab Approved to Start China Trials of Interleukin-7 Immunotherapy

I-Mab Biopharma of  Shanghai reported the China National Medical Products Administration approved its IND for TJ107 (HyLeukin®), a novel long-acting recombinant human interleukin-7 (rhIL-7). ...

Genexine Inc 095700 Financial and Strategic SWOT Analysis Review [Report Updated: 08062018] Prices from USD $300

SummaryGenexine Inc Genexine, formerly Genexine Co Ltd is a biotechnology company that develops and commercialize immunotherapeutics and next generation novel longacting biologics. The company develop...

Korean Firms Join Hands To Pick Up Troubled US Cancer Vaccine Firm Argos

Argos Therapeutics lands in the hands of Genexine and SCM Lifescience after the US immunotherapy firm was put up for...   

Genexine Inc 095700 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17042018] Prices from USD $250

SummaryGenexine Inc Genexine, formerly Genexine Co Ltd is a biotechnology company that develops and commercialize immunotherapeutics and next generation novel longacting biologics. The company develop...

Genexine Inc 095700 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryGenexine Inc Genexine, formerly Genexine Co Ltd is a clinical stage biotechnology company that develops and commercialize immunotherapeutics and next generation novel longacting biologics. The ...

Genexine Inc 095700 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryGenexine Inc Genexine, formerly Genexine Co Ltd is a clinical stage biotechnology company that develops and commercialize immunotherapeutics and next generation novel longacting biologics. The ...

Ichor Medical Systems Announces Utilization of Its Investigational TriGrid Delivery System in a Clinical Trial Evaluating GX-188E Vaccine Combined with a Checkpoint Inhibitor for Treatment of Cervical Cancer

Ichor Medical Systems, Inc. (Ichor) announced today that its investigational TriGrid® Delivery System (TriGrid) is being utilized in a Phase 1b/2 clinical trial to administer GX...

NeoImmuneTech Announces Initiation of Clinical Trial for HyLeukin-7 Treatment in Combination with Standard Therapy for Newly Diagnosed Brain Cancer Patients

NeoImmuneTech, Inc., an immunotherapy drug development company focused on advanced cancer treatments, today announced the U.S. Food and Drug Administration (FDA) approved i...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Genexine, Inc.

Genexine, Inc., listed on KOSDAQ (095700) since 2009, is a leading biotherapeutics company focused on immuno-oncology and orphan disease. Genexine has robust pipelines in clinical...

Genexine Inc.

Genexine, Inc, listed on KOSDAQ (095700-KQ) since 2009, is a clinical stage biotherapeutics company focused on immuno-oncology,metabolic and autoimmune diseases. Genexine has robu...

NeoImmuneTech, Inc.

NeoImmuneTech (NIT), a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, Hyleukin-7, in the U.S. and ...

NeoImmuneTech

NeoImmuneTech, a Genexine related company founded in 2014, is focused on leading the development efforts for its flagship immunotherapy product, HyLeukin-7, in the US and EU. Base...

Ichor Medical Systems

Ichor Medical Systems’ TriGrid™ Delivery System is the first integrated and fully automated system for electroporation-mediated DNA administration in humans. Ichor, a pr...

More Information about "Genexine, Inc." on BioPortfolio

We have published hundreds of Genexine, Inc. news stories on BioPortfolio along with dozens of Genexine, Inc. Clinical Trials and PubMed Articles about Genexine, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Genexine, Inc. Companies in our database. You can also find out about relevant Genexine, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record